INO logoINO
Inovio Pharmaceuticals Inc

92,711
Loading...
Loading...
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
134

Frequently Asked Questions

What is Market Cap of Inovio Pharmaceuticals Inc?
What is the 52-week high for Inovio Pharmaceuticals Inc?
What is the 52-week low for Inovio Pharmaceuticals Inc?
What is Inovio Pharmaceuticals Inc stock price today?
What was Inovio Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Inovio Pharmaceuticals Inc?
What is the Price-to-Book ratio of Inovio Pharmaceuticals Inc?
What is the 50-day moving average of Inovio Pharmaceuticals Inc?
How many employess does Inovio Pharmaceuticals Inc has?

Latest INO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.